Literature DB >> 29754311

Impact of combined antibiotic treatment on multidrug-resistant bacteria emergence after postoperative intra-abdominal infections : Discussion on the DURAPOP randomised clinical trial.

Pierre Simeone1,2, David Lagier3, Djamel Mokart4, Philippe Montravers5, Marina Esposito-Farèse6, Sigismond Lasocki7, Herve Dupont8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29754311     DOI： 10.1007/s00134-018-5215-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

2.  Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.

Authors:  M J Dinubile; I Friedland; C Y Chan; M R Motyl; H Giezek; M Shivaprakash; R A Weinstein; J P Quinn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

Review 3.  Individualising Therapy to Minimize Bacterial Multidrug Resistance.

Authors:  A J Heffernan; F B Sime; J Lipman; J A Roberts
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

4.  Guidelines for management of intra-abdominal infections.

Authors:  Philippe Montravers; Hervé Dupont; Marc Leone; Jean-Michel Constantin; Paul-Michel Mertes; Pierre-Francois Laterre; Benoit Misset; Jean-Pierre Bru; Rémy Gauzit; Albert Sotto; Cecile Brigand; Antoine Hamy; Jean-Jacques Tuech
Journal:  Anaesth Crit Care Pain Med       Date:  2015-04-24       Impact factor: 4.132

5.  Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.

Authors:  Philippe Montravers; Florence Tubach; Thomas Lescot; Benoit Veber; Marina Esposito-Farèse; Philippe Seguin; Catherine Paugam; Alain Lepape; Claude Meistelman; Joel Cousson; Antoine Tesniere; Gaetan Plantefeve; Gilles Blasco; Karim Asehnoune; Samir Jaber; Sigismond Lasocki; Herve Dupont
Journal:  Intensive Care Med       Date:  2018-02-26       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.